Story
Latigo Biotherapeutics Prices $345.6 Million IPO at $18 Per Share

Latigo Biotherapeutics, Inc., a clinical-stage company developing non-opioid pain medications, has priced its initial public offering of 19.2 million shares at $18.00 per share. The offering is expected to generate gross proceeds of approximately $345.6 million before underwriting discounts and commissions, according to a company press release dated August 6, 2026.
Offering Details
The IPO provides investors with a new opportunity in the biopharmaceutical sector, with shares scheduled to begin trading on the Nasdaq Global Select Market on August 7, 2026, under the ticker symbol LTGO. The offering is expected to close on August 10, 2026, subject to customary closing conditions.
Key details of the public offering include:
- Shares Offered: 19,200,000 shares of common stock.
- Price Per Share: $18.00.
- Gross Proceeds: Approximately $345.6 million.
- Underwriter Option: Underwriters have a 30-day option to purchase up to an additional 2,880,000 shares at the IPO price.
AdStrategic Focus and Market Context
Latigo Biotherapeutics is focused on addressing the need for non-opioid pain medicines. The company's lead product candidate, LTG-001, is an oral Nav1.8 inhibitor being developed for the treatment of acute pain. The capital raised from the IPO is expected to fund further clinical development of its pipeline.
The U.S. Securities and Exchange Commission (SEC) declared the company's registration statement effective on August 6, 2026. The offering is being managed by a syndicate of joint book-running managers that includes Goldman Sachs & Co. LLC, Jefferies, Leerink Partners, and Guggenheim Securities, indicating strong institutional interest.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.